Solid Tumors or Lymphoma
1 clinical trials · Condition
◉ Watch Solid Tumors or Lymphoma
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability and Preliminary Efficacy of IBI363 in Subjects With Advanced Solid Tumors or Lymphoma (NCT05460767) | Innovent Biologics (Suzhou) Co. Ltd. | 2022-08-31 |
Track Solid Tumors or Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.